Corona Remedies IPO GMP - Live Grey Market Premium

Alloted
Corona Remedies IPO

Corona Remedies Limited is an India-focused branded pharmaceutical company specializing in developing and marketing products across high-growth chronic therapeutic areas, primarily women’s healthcare, cardio-diabeto, pain management, and urology. The company is recognized as the second-fastest-growing among the top 30 firms in the Indian Pharmaceutical Market (IPM) by domestic sales. It operates two manufacturing facilities in Gujarat and Himachal Pradesh and leverages a pan-India marketing network of 2,671 medical representatives.

Issue Price
1062
Current GMP
342
GMP %
+32.20
Est. Listing Price
1404
Advertisement

IPO Details

Price Range
₹1008.0 - ₹1062.0
Issue Size
₹655.37 Cr
Lot Size
14 shares
IPO Type
Mainboard
Open Date
8 Dec 2025
Close Date
10 Dec 2025
Allotment Date
11 Dec 2025
Listing Date
15 Dec 2025

GMP Timeline

DateIPO PriceGMPEst. Price% Change
11 Dec 2025Live
1062
291
1353
+27.40
10 Dec 2025
1062
295
1357
+27.78
9 Dec 2025
1062
270
1332
+25.42
8 Dec 2025
1062
262
1324
+24.67
7 Dec 2025
1062
290
1352
+27.31
6 Dec 2025
1062
305
1367
+28.72
5 Dec 2025
1062
365
1427
+34.37
4 Dec 2025
1062
365
1427
+34.37
3 Dec 2025
1062
307
1369
+28.91
2 Dec 2025
1062
0
1062
0.00
Advertisement

Important Notes About Grey Market Premium

Grey Market Premium (GMP) is an unofficial value that indicates investor sentiment before the IPO listing. It is the premium amount at which IPO shares are traded in the grey market before they are officially listed on the stock exchange.

GMP fluctuates based on market conditions and investor sentiment. A positive GMP suggests the market expects the stock to list above its issue price, while a negative GMP suggests it may list below the issue price.

The actual listing price may differ from the estimated price based on GMP due to market conditions on the listing day. GMP is not an official indicator and should not be the sole basis for investment decisions.

IPOwiz updates the GMP values regularly, but these values are sourced from unofficial channels and should be used as a reference only.

Back to GMP TrackerView Full IPO Details

Frequently Asked Questions

What is GMP (Grey Market Premium)?
GMP (Grey Market Premium) is the premium at which IPO shares are traded in the unofficial market before official listing. It indicates market sentiment and expected listing price. A positive GMP suggests strong demand, while negative GMP indicates weak market sentiment.
What is the current GMP for Corona Remedies IPO?
The current GMP for Corona Remedies IPO is ₹342. This represents a 32.20% premium over the issue price of ₹1062.
What is the estimated listing price based on current GMP?
Based on the current GMP of ₹342 and issue price of ₹1062, the estimated listing price for Corona Remedies IPO is ₹1404. However, the actual listing price may differ based on market conditions on 15 December 2025.
How is GMP calculated?
GMP is determined by market demand and supply in the unofficial grey market. It's the difference between the expected listing price and the issue price. Higher GMP indicates strong demand and investor confidence, while lower or negative GMP suggests weak demand.
Is GMP reliable for IPO investment decisions?
GMP provides market sentiment but shouldn't be the sole factor for investment decisions. It's unofficial and can change daily. Consider company fundamentals, financials, market conditions, and your risk appetite before investing. GMP is a reference indicator, not a guarantee.
Can GMP change before listing?
Yes, GMP is highly volatile and can change daily based on market conditions, subscription levels, overall market sentiment, and news about the company. The GMP you see today may be different tomorrow, and it can change until 15 December 2025.
What happens if GMP is negative?
A negative GMP indicates the stock may list below the issue price, suggesting weak market demand. However, actual listing price may differ from GMP predictions, and negative GMP doesn't guarantee a loss.
How does GMP affect IPO subscription?
High GMP often correlates with high subscription rates as investors expect good listing gains. However, this isn't always true. Some IPOs with high GMP may have lower subscription if investors are cautious. GMP reflects market sentiment, which can influence subscription behavior.
What is the estimated profit based on GMP?
For a lot size of 14 shares, the estimated profit based on current GMP of ₹342 is ₹4,788. This is calculated as: Lot Size × GMP × Number of Lots. Note: This is an estimate and actual listing price may vary.